World Scientific Annual Review of Vaccine Design (WSARVD)

Vaccines have been an indispensable tool to protect the world against many deadly infectious agents. This is further evidenced by the rapid development of vaccines that greatly contributed to the control and management of COVID-19. New delivery platforms such as mRNA allow variant specific vaccines to address the rapid viral mutation rates, and this versatile technology will also expand into the field of therapeutic vaccines targeting diseases such as oncology, autoimmunity, and metabolic syndromes. The World Scientific Annual Review of Vaccine Design (WSARVD) aims to publish reviews that will contribute to the knowledge of how to make better vaccines, especially towards improving efficacy, safety, durability, manufacturing, and cost management. The scope of this journal includes topics such as nucleic acid-based vaccines, subunit vaccines, carriers and delivery platforms, adjuvants, immunization protocols, immune response, efficacy studies, preclinical and clinical trials, neutralization and cellular assays, and correlates of protection assessment.

World Scientific Annual Review of Vaccine Design (WSARVD) is :-

• International, Peer-Reviewed, Open Access, Refereed, Vaccine Design, metabolic syndromes , Online or Print , Yearly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2972-4287, E-ISSN: 2972-4295, Established: 2000,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE